康西普治療公司
US ˙ NasdaqCM ˙ US2183521028

SecurityCORT / Corcept Therapeutics Incorporated
InstitutionONEQ - Fidelity Nasdaq Composite Index Tracking Stock
Latest Disclosed Ownership25,463 shares
Latest Disclosed Value $ 1,974,910
ONEQ - Fidelity Nasdaq Composite Index Tracking Stock reports 14.55% decrease in ownership of CORT / Corcept Therapeutics Incorporated

On July 24, 2025 - ONEQ - Fidelity Nasdaq Composite Index Tracking Stock filed a NPORT-P form disclosing ownership of 25,463 shares of Corcept Therapeutics Incorporated (US:CORT) valued at $1,974,910 USD as of May 31, 2025. The entity filed a previous NPORT-P on April 25, 2025 disclosing 29,797 shares of Corcept Therapeutics Incorporated. This represents a change in shares of -14.55% during the quarter. The current value of the position is $1,849,123 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-07-24 2025-05-31 NP CORCEPT THERAPEUTICS EC US2183521028 25,463 -4,334 -14.55 1,975 9.36 0.0261
2025-04-25 2025-02-28 NP CORCEPT THERAPEUTICS EC US2183521028 29,797 -1,126 -3.64 1,805 1.23 0.0243
2025-01-27 2024-11-30 NP CORCEPT THERAPEUTICS EC US2183521028 30,923 -812 -2.56 1,784 59.20 0.0242
2024-10-29 2024-08-31 NP CORCEPT THERAPEUTICS EC US2183521028 31,735 304 0.97 1,120 18.14 0.0166
2024-07-26 2024-05-31 NP CORCEPT THERAPEUTICS EC US2183521028 31,431 400 1.29 948 30.04 0.0150
2024-04-24 2024-02-29 NP CORCEPT THERAPEUTICS EC US2183521028 31,031 496 1.62 729 -6.18 0.0122
2024-01-24 2023-11-30 NP CORCEPT THERAPEUTICS EC US2183521028 30,535 -1,016 -3.22 778 -24.71 0.0149
2023-10-27 2023-08-31 NP CORCEPT THERAPEUTICS EC US2183521028 31,551 510 1.64 1,033 41.56 0.0202
2023-07-26 2023-05-31 NP CORCEPT THERAPEUTICS EC US2183521028 31,041 102 0.33 729 13.20 0.0157
2023-04-27 2023-02-28 NP CORCEPT THERAPEUTICS EC US2183521028 30,939 765 2.54 644 -15.49 0.0158
2023-01-26 2022-11-30 NP CORCEPT THERAPEUTICS EC US2183521028 30,174 799 2.72 763 0.53 0.0191
2022-10-26 2022-08-31 NP CORCEPT THERAPEUTICS EC US2183521028 29,375 1,139 4.03 758 28.91 0.0190
2022-07-29 2022-05-31 NP CORCEPT THERAPEUTICS EC US2183521028 28,236 170 0.61 588 -5.92 0.0150
2022-04-28 2022-02-28 NP CORCEPT THERAPEUTICS EC US2183521028 28,066 0 0.00 626 6.11 0.0145
2022-01-25 2021-11-30 NP CORCEPT THERAPEUTICS EC US2183521028 28,066 731 2.67 589 1.38 0.0123
2021-10-26 2021-08-31 NP CORCEPT THERAPEUTICS EC US2183521028 27,335 561 2.10 582 0.52 0.0127
2021-07-22 2021-05-31 NP CORCEPT THERAPEUTICS EC US2183521028 26,774 90 0.34 578 -13.86 0.0144
2021-04-23 2021-02-28 NP CORCEPT THERAPEUTICS EC US2183521028 26,684 -12,377 -31.69 671 -24.10 0.0175
2021-01-20 2020-11-30 NP CORCEPT THERAPEUTICS EC US2183521028 39,061 12,099 44.87 884 158.48 0.0264
2020-10-16 2020-08-31 NP CORCEPT THERAPEUTICS EC US2183521028 26,962 494 1.87 342 -14.50 0.0106
2020-07-20 2020-05-31 NP CORCEPT THERAPEUTICS EC US2183521028 26,468 170 0.65 401 20.85 0.0156
2020-04-24 2020-02-29 NP CORCEPT THERAPEUTICS EC US2183521028 26,298 3,901 17.42 332 15.33 0.0148
2020-01-16 2019-11-30 NP CORCEPT THERAPEUTICS EC US2183521028 22,397 22,397 287 0.0130
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.